- Winners
- AMGEN S.A., BIOCON BIOLOGICS SPAIN S.L., BIOGEN SPAIN S.L., FRESENIUS KABI ESPAÑA, S.A., KERN PHARMA, S.L., Sandoz Farmaceutica
- Contract value
- €167,054,205
- Bids received
- 6
- Published
- 13 Jan 2026
- Awarded
- 7 Jan 2026
- Contract start
- 7 Jan 2026
- Contract end
- 8 Jan 2027estimated
- Region
- Madrid